首页 | 官方网站   微博 | 高级检索  
     

SARS病毒膜融合抑制剂的鉴定
引用本文:潘浩,陈永井,周迎会,吴士良. SARS病毒膜融合抑制剂的鉴定[J]. 江苏大学学报(医学版), 2006, 16(3): 200-203,F0005
作者姓名:潘浩  陈永井  周迎会  吴士良
作者单位:苏州大学医学院生物化学与分子生物学教研室;苏州大学附属第一医院;苏州大学医学生物技术研究所,江苏,苏州,215123;苏州大学医学院生物化学与分子生物学教研室
基金项目:江苏省高校自然科学基金
摘    要:目的:用分子对接技术预测HIV融合抑制剂是否能对SAILS起作用。方法:搜寻HIVsp41融合抑制剂,用DOCK软件分析其与SAILS蛋白的S2结构域HRl三聚体晶体结构的亲和力。结果:预测了23个小分子。ADS-J1、ADS-J2、XTYFormazan等几个小分子得分较高,提示与S2结构域有亲和力。结论:发现抗HIV的融合抑制剂有可能对SARS起作用。

关 键 词:SARS  DOCK  融合抑制剂  S蛋白
文章编号:1671-7783(2006)03-0200-04
收稿时间:2006-05-16
修稿时间:2006-05-16

Identifying inhibitors of the SARS coronavirus membrane fusion
PAN Hao,CHEN Yong-jing,ZHOU Ying-hui,WU Shi-liang. Identifying inhibitors of the SARS coronavirus membrane fusion[J]. Journal of Jiangsu University Medicine Edition, 2006, 16(3): 200-203,F0005
Authors:PAN Hao  CHEN Yong-jing  ZHOU Ying-hui  WU Shi-liang
Affiliation:1. Department of Biochemistry and Molecular Biology, Soochow University; 2. the First Affiliated Hospital of Soochow University; 3. Institute of Medical Biotechnology, Soochow University, Suzhou Jiangsu 215123, China
Abstract:Objective: We used docking techniques to investigate whether chemical compounds which inhibit HIV membrane fusion have the ability against fusion of SARS-CoV with target cells.Methods: We searched and selected the chemical compounds against HIV membrane fusion from PubChem database.The binding affinities of HIV fusion inhibitors to SARS-CoV central HR1 coiled coil structure were predicated using DOCK version 5.1.1. Results: The ADS-J1,ADS-J2,XTT Formazan have binding affinities for SARS fusion core,because they obtained high score in docking calculations. Conclusion: Existing HIV membrane fusion inhibitors may have the similar inhibiting activities against SARS-CoV
Keywords:SARS  DOCK
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号